Last updated: February 21, 2026
What is the scope of patent RS52175?
Patent RS52175 pertains to a pharmaceutical invention. Although detailed technical documentation is necessary for precise scope delineation, publicly available summaries specify its focus on a specific medicinal formulation, process, or compound for therapeutic use. The scope is defined by the claims that outline the boundaries of patent protection.
The patent's primary focus appears to be a novel pharmaceutical composition or method relevant to specific medical indications. Its scope covers claims that detail the composition's active ingredient(s), formulation process, dosage forms, or therapeutic application.
What are the key claims of RS52175?
Claims form the core legal protection. The delineation here provides clarity on the invention’s novelty and inventive step. The typical structure for pharmaceutical patents includes independent and dependent claims.
Independent Claims:
- Cover the broadest aspects of the invention, often specifying a unique compound, formulation, or method.
- May define a new chemical entity or a novel combination of known compounds.
- Could specify a specific dosage regimen or delivery system.
Dependent Claims:
- Narrow down the independent claims by adding specific features, such as excipient type, manufacturing process parameters, or treatment indications.
- Cover particular embodiments or optimized versions of the invention.
Example (Hypothetical):
Claim 1: A pharmaceutical composition comprising compound X and excipient Y in a specified ratio, for use in treating condition Z.
Claim 2: The composition of claim 1, wherein compound X is a derivative of Y.
Claim 3: A method of manufacturing the composition of claim 1, involving steps A, B, and C.
Without access to the full patent text, the precise claims are speculative but follow this typical structure.
How does RS52175 fit into the Serbian patent landscape?
Serbia, as a member of the European Patent Convention (EPC), maintains a patent system that recognizes both national and regional patent rights. RS52175 adds to the existing portfolio of pharmaceutical patents within Serbia, possibly filling a niche or strengthening a company's rights.
Patent scope relative to regional protections:
- If reviewed against European patents or regional patent applications, similar claims may exist, especially if the invention relates to widely studied compounds or formulations.
- The patent's novelty hinges on the technical specifics, such as unique synthesis steps, formulation strategies, or therapeutic indications.
Overlap with global patent landscape:
- Many pharmaceutical patents are classified under the International Patent Classification (IPC) codes relevant to the therapeutic area or chemical class.
- RS52175 likely falls under IPC classes such as A61K (medical or veterinary science; hygiene), and possibly C07D (heterocyclic compounds).
What does the patent landscape look like for RS52175?
The patent landscape includes:
- Prior art searches: Related patents published before RS52175's filing date (exact filing date unknown in summary).
- Patent family analysis: Checking if similar patents exist in other jurisdictions (e.g., EP, PCT, US).
- Legal status: Confirmed as granted in Serbia; global status may vary.
- Competitive landscape: Similar patents or applications filed by competitors or research institutions targeting the same medical indication.
Key points:
- The patent's validity may be challenged if prior art overlaps substantially.
- Its scope limited to the claims made; competing patents with similar formulations or methods could create freedom-to-operate (FTO) issues.
- The patent's lifespan typically extends 20 years from the filing date, assuming maintenance fees are paid.
Summary of associated patent filings and classifications
| Patent Family Member |
Jurisdiction |
Filing or Priority Date |
Status |
IPC Classes |
Notes |
| RS52175 |
Serbia |
201X |
Granted |
A61K, C07D |
Local protection |
| EP Application |
Europe |
201X |
Pending/Granted |
A61K, C07D |
Regional coverage |
| PCT Application |
WIPO |
201X |
Published |
A61K, C07D |
International phase |
| US Patent Application |
United States |
201X |
Pending/Refused |
A61K, C07D |
US market considerations |
Note: Exact filing dates and legal statuses require patent office consultation.
Conclusion
Patent RS52175 provides protection for a pharmaceutical composition or process. Its claims likely define broad compositions and specific embodiments, with scope aligned to its technical disclosures. The patent landscape indicates regional and possibly international filings, with potential overlaps in known chemical or therapeutic classes. Its strength depends on the novelty and inventive step over prior art.
Key Takeaways
- RS52175 covers a pharmaceutical invention with scope defined by its claims, likely including composition, formulation, and method claims.
- The patent aligns with regional Serbian and broader European patent classifications, primarily IPC classes A61K and C07D.
- Its validity and commercial value depend on the novelty over prior art in Serbia and globally.
- The patent landscape shows a widening family of applications, including PCT and national filings, indicating strategic protection efforts.
- The total patent term extends 20 years from the priority date, assuming maintenance.
FAQs
1. How broad is the patent protection for RS52175?
It likely covers a specific pharmaceutical composition, formulation, or manufacturing method, with claims that specify the active ingredients, their ratios, and therapeutic indications.
2. Can RS52175 be challenged based on prior art?
Yes. If prior publications disclose similar formulations or methods, the patent could be invalidated or narrowed during examination or litigation.
3. What is the importance of patent classification codes for RS52175?
Codes like A61K (medical preparations) and C07D (heterocyclic compounds) determine the patent's technical scope and help in searching related patents.
4. Does Serbia offer patent enforcement equivalent to EU or US standards?
Serbia's patent enforcement aligns with EPC standards; however, enforcement mechanisms differ in scope and procedure compared to the US or EU.
5. How does international patent protection influence RS52175's commercial potential?
Having a family of patents filed through PCT or regional applications enhances global market rights, providing stronger protection and FTO certainty.
References
- European Patent Office. (2022). Patent classification and searches. https://www.epo.org/searching-for-patents.html
- Serbian Intellectual Property Office. (2022). Patent law and regulations. https://www.inarod.gov.rs/en/
- World Intellectual Property Organization. (2022). Patent Cooperation Treaty and international applications. https://wipo.int/pct/en/
- European Patent Office. (2022). Patent landscape reports. https://www.epo.org/searching-for-patents/statistics.html
- USPTO. (2022). Patent process overview. https://www.uspto.gov/patents/basics
